Vaxinano is specialized in the development of prophylactic and therapeutic vaccines for infectious diseases, for human and animal health markets. The Vaxinano nanoparticles vaccines platform is safe-by-design, more stable and efficient, adjuvant- and needle-free. Vaxinano develops a first application in human toxoplasmosis
